The common indication among all GLP-1 drugs is type 2 diabetes: they are prescribed for patients whose hemoglobin A1C is greater than 8.5%, who have a need for weight loss and who have a need to avoid hypoglycemia
Weight Loss Results at 48 Weeks: Key Percentage Findings At 48 weeks, the 12 mg retatrutide dose produced a mean body weight reduction of approximately 24.2%, compared with approximately 2.1% in the placebo group, with weight loss still ongoing at trial end
pharmacies and select telehealth providers in early January, a Novo Nordisk spokesperson told Scientific American
Pairing the protocol with 80 to 100g daily protein and resistance training two to three times weekly is the strategy that protects muscle composition
Achieve Sustainable Weight Loss Clinically Proven Treatments Balanced Nutrition Plan Expert Professional Guidance What Benefits Has Retatrutide Shown in Clinical Research
Yes, there are other treatments for Type 2 diabetes, such as metformin, SGLT2 inhibitors, and insulin